ShAG VPERED K POBEDE NAD IZZhOGOY
- Авторлар: Lazebnik L.B1, Li E.D1
-
Мекемелер:
- Шығарылым: № 6 (2013)
- Беттер: 44-48
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/280491
- ID: 280491
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
The article discusses the problems of acid-related diseases and heartburn. The data of studies on the prevalence, terminology, diagnostic criteria, and treatment of diseases accompanied by heartburn are presented. As a modern drugs of pathogenetic therapy, proton pump inhibitors should be considered, among which Omez® Insta (omeprazole) has beneficial pharmacokinetic effects for the patients.
Негізгі сөздер
Толық мәтін
Әдебиет тізімі
- Castell D, Bagin R, Goldlust B, et al. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005;21 ( 12): 1467-74.
- Katz P, Koch F, Ballard E, et al. Comparison of the effects of immediate- release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms. Aliment Pharmacol Ther 2007; 25(2): 197-205.
- Tutuian R, Castell D. Nocturnal acid breakthrough - approach to management. Med Gen Med 2004;6(4):11.
- Gerson L, Mitra S, Sato T, et al. Control of Intra-E sophageal pH in Patients With Barrett's Esophagus on Zegerid (Omeprazole-Sodium Bicarbonate) 40 mg Twice Daily. Gastrointest
- Исаков В.А. Эпидемиология ГЭРБ: Восток и Запад // Экспериментальная и клиническая гастроэнтерология. Специальный выпуск 2004. № 5. С. 2-6.
- Экспериментальная и клиническая гастроэнтерология 2010;5:113-18.
- Не Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management - the Genval Workshop report. Gut 1999; 44:1-16.
- Мананников И.В. Эпидемиология гастроэзофагорефлюксной болезни в Москве. Дисс. канд. мед. наук. М., 2005.
- Kahrilas PI, Falk IV, Johnson DA, et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. Aliment Pharmacol Ther 2000:14:1249-58.
- Инструкция по медицинскому применению препарата Омез® Инста.
Қосымша файлдар
